Everything in the comment above is pure rubbish, here are the...

First 19 Last

Share
Profile

Follow
Thegreatj11

291 Posts.

10/09/16

09:54

Post #: 19066752
Share

Originally posted by J8 ↑

Yes Hoy, it seems that a lot of RNAi requires chemical help. Agreed, pharma may like the idea but their drugs would only be used for a very short time. Not much in that for them but what you say is definitely on the cards.

I am wondering what they can do to deviate much from TT. Different shrnas, same vector but something else new?? The IND could be an issue if we change it too much...... but if pharma are in, the IND gets a lot easier.

What about using a fourth or fifth shrna? The use of a fourth and fifth drug works well in many cases of HCV when relapse occurs.

A friend, who is cirrhotic and has the difficult to treat G3 HCV, recently relapsed after a six month course of Sof/Dac. She will be re-treated with an experimental, five or six pronged cocktail. (Before you ask Blane..... we are going to add Sofosbuvir to Vpak and then add Riba after one month.)

I'm sure that eventually they will find better and better combinations of shrnas that won't require chemical help.

Expand

Everything in the comment above is pure rubbish, here are the facts, the transduction rates are better in humans than in animals, all shrnas are being dectected, sustained knockdown has been observed in all humanized animal models and in primates and liver on a chip, the drug works sorry bro

BLT Price at posting: 12.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

There are more pages in this discussion • 41 more messages in this thread...

First 19 Last

Add BLT (ASX) to my watchlist

Everything in the comment above is pure rubbish, here are the...

Top Stories

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

ASX hits all time high out the gate on Friday trades following bullish US inflation data

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Immutep reports strong response rate from immunotherapies treating carcinomas

Featured News